vs
RESOURCES CONNECTION, INC.（RGP）与再鼎医药（ZLAB）财务数据对比。点击上方公司名可切换其他公司
再鼎医药的季度营收约是RESOURCES CONNECTION, INC.的1.1倍（$127.1M vs $117.7M），再鼎医药同比增速更快（17.1% vs -19.2%），RESOURCES CONNECTION, INC.自由现金流更多（$15.6M vs $-26.7M），过去两年再鼎医药的营收复合增速更高（20.8% vs -11.8%）
RGP原名 Resources Global Professionals，是 Resources Connection, Inc. 的核心运营主体，面向全球客户提供多领域专业咨询服务，覆盖财务会计、信息管理、治理风险合规、人力资本、法务监管、企业咨询与重组、战略传播以及供应链管理等板块。
再鼎医药是一家创新生物制药企业，专注于肿瘤、自身免疫性疾病、感染性疾病等领域创新疗法的研发、生产与商业化，核心市场覆盖大中华区，与全球多家头部生物科技企业合作，为存在未被满足医疗需求的患者提供治疗方案。
RGP vs ZLAB — 直观对比
营收规模更大
ZLAB
是对方的1.1倍
$117.7M
营收增速更快
ZLAB
高出36.3%
-19.2%
自由现金流更多
RGP
多$42.3M
$-26.7M
两年增速更快
ZLAB
近两年复合增速
-11.8%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $117.7M | $127.1M |
| 净利润 | $-12.7M | — |
| 毛利率 | 37.1% | 51.0% |
| 营业利润率 | -10.3% | -54.6% |
| 净利率 | -10.8% | — |
| 营收同比 | -19.2% | 17.1% |
| 净利润同比 | 81.6% | — |
| 每股收益（稀释后） | $-0.38 | $-0.05 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收RGPZLAB
| Q4 25 | $117.7M | $127.1M | ||
| Q3 25 | $120.2M | $115.4M | ||
| Q2 25 | $139.3M | $109.1M | ||
| Q1 25 | $129.4M | $105.7M | ||
| Q4 24 | $145.6M | $108.5M | ||
| Q3 24 | $136.9M | $101.8M | ||
| Q2 24 | $148.2M | $100.1M | ||
| Q1 24 | $151.3M | $87.1M |
净利润RGPZLAB
| Q4 25 | $-12.7M | — | ||
| Q3 25 | $-2.4M | $-36.0M | ||
| Q2 25 | $-73.3M | $-40.7M | ||
| Q1 25 | $-44.1M | $-48.4M | ||
| Q4 24 | $-68.7M | — | ||
| Q3 24 | $-5.7M | $-41.7M | ||
| Q2 24 | $10.5M | $-80.3M | ||
| Q1 24 | $2.5M | $-53.5M |
毛利率RGPZLAB
| Q4 25 | 37.1% | 51.0% | ||
| Q3 25 | 39.5% | 59.5% | ||
| Q2 25 | 40.2% | 60.6% | ||
| Q1 25 | 35.1% | 63.6% | ||
| Q4 24 | 38.5% | 61.5% | ||
| Q3 24 | 36.5% | 64.1% | ||
| Q2 24 | 40.2% | 64.9% | ||
| Q1 24 | 37.0% | 61.4% |
营业利润率RGPZLAB
| Q4 25 | -10.3% | -54.6% | ||
| Q3 25 | -1.7% | -42.3% | ||
| Q2 25 | -47.0% | -50.3% | ||
| Q1 25 | -38.4% | -53.3% | ||
| Q4 24 | -52.7% | -62.6% | ||
| Q3 24 | -3.5% | -66.6% | ||
| Q2 24 | 7.6% | -76.0% | ||
| Q1 24 | 2.8% | -80.7% |
净利率RGPZLAB
| Q4 25 | -10.8% | — | ||
| Q3 25 | -2.0% | -31.2% | ||
| Q2 25 | -52.6% | -37.3% | ||
| Q1 25 | -34.0% | -45.8% | ||
| Q4 24 | -47.2% | — | ||
| Q3 24 | -4.2% | -40.9% | ||
| Q2 24 | 7.1% | -80.2% | ||
| Q1 24 | 1.7% | -61.4% |
每股收益（稀释后）RGPZLAB
| Q4 25 | $-0.38 | $-0.05 | ||
| Q3 25 | $-0.07 | $-0.03 | ||
| Q2 25 | $-2.21 | $-0.04 | ||
| Q1 25 | $-1.34 | $-0.04 | ||
| Q4 24 | $-2.08 | $-0.09 | ||
| Q3 24 | $-0.17 | $-0.04 | ||
| Q2 24 | $0.31 | $-0.08 | ||
| Q1 24 | $0.08 | $-0.05 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $89.8M | $689.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $194.6M | $715.5M |
| 总资产 | $289.3M | $1.2B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资RGPZLAB
| Q4 25 | $89.8M | $689.6M | ||
| Q3 25 | $77.5M | $717.2M | ||
| Q2 25 | $86.1M | $732.2M | ||
| Q1 25 | $72.5M | $757.3M | ||
| Q4 24 | $78.2M | $779.7M | ||
| Q3 24 | $89.6M | $616.1M | ||
| Q2 24 | $108.9M | $630.0M | ||
| Q1 24 | $113.8M | $650.8M |
股东权益RGPZLAB
| Q4 25 | $194.6M | $715.5M | ||
| Q3 25 | $206.4M | $759.9M | ||
| Q2 25 | $207.1M | $791.7M | ||
| Q1 25 | $277.8M | $810.8M | ||
| Q4 24 | $325.7M | $840.9M | ||
| Q3 24 | $407.2M | $667.7M | ||
| Q2 24 | $418.8M | $704.2M | ||
| Q1 24 | $414.9M | $762.2M |
总资产RGPZLAB
| Q4 25 | $289.3M | $1.2B | ||
| Q3 25 | $287.2M | $1.2B | ||
| Q2 25 | $304.7M | $1.2B | ||
| Q1 25 | $375.6M | $1.2B | ||
| Q4 24 | $424.9M | $1.2B | ||
| Q3 24 | $512.9M | $985.3M | ||
| Q2 24 | $510.9M | $987.4M | ||
| Q1 24 | $523.2M | $988.4M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.9M | $-26.0M |
| 自由现金流经营现金流 - 资本支出 | $15.6M | $-26.7M |
| 自由现金流率自由现金流/营收 | 13.2% | -21.0% |
| 资本支出强度资本支出/营收 | 0.3% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $24.3M | $-158.9M |
8季度趋势，按日历期对齐
经营现金流RGPZLAB
| Q4 25 | $15.9M | $-26.0M | ||
| Q3 25 | $-7.8M | $-32.0M | ||
| Q2 25 | $16.8M | $-31.0M | ||
| Q1 25 | $659.0K | $-61.7M | ||
| Q4 24 | $1.8M | $-55.8M | ||
| Q3 24 | $-309.0K | $-26.8M | ||
| Q2 24 | $3.2M | $-42.2M | ||
| Q1 24 | $20.5M | $-90.1M |
自由现金流RGPZLAB
| Q4 25 | $15.6M | $-26.7M | ||
| Q3 25 | $-8.0M | $-35.0M | ||
| Q2 25 | $16.5M | $-33.9M | ||
| Q1 25 | $238.0K | $-63.2M | ||
| Q4 24 | $61.0K | $-58.4M | ||
| Q3 24 | $-575.0K | $-28.2M | ||
| Q2 24 | $3.0M | $-42.9M | ||
| Q1 24 | $20.4M | $-91.1M |
自由现金流率RGPZLAB
| Q4 25 | 13.2% | -21.0% | ||
| Q3 25 | -6.6% | -30.4% | ||
| Q2 25 | 11.8% | -31.1% | ||
| Q1 25 | 0.2% | -59.9% | ||
| Q4 24 | 0.0% | -53.8% | ||
| Q3 24 | -0.4% | -27.7% | ||
| Q2 24 | 2.1% | -42.9% | ||
| Q1 24 | 13.5% | -104.5% |
资本支出强度RGPZLAB
| Q4 25 | 0.3% | 0.5% | ||
| Q3 25 | 0.1% | 2.6% | ||
| Q2 25 | 0.2% | 2.6% | ||
| Q1 25 | 0.3% | 1.5% | ||
| Q4 24 | 1.2% | 2.4% | ||
| Q3 24 | 0.2% | 1.3% | ||
| Q2 24 | 0.1% | 0.7% | ||
| Q1 24 | 0.1% | 1.1% |
现金转化率RGPZLAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.30× | — | ||
| Q1 24 | 8.04× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
RGP
| US | $93.7M | 80% |
| Non Us | $24.0M | 20% |
ZLAB
| Zejula | $56.0M | 44% |
| Other | $21.9M | 17% |
| Nuzyra | $16.0M | 13% |
| Optune | $11.9M | 9% |
| XACDURO | $10.7M | 8% |
| Qinlock | $9.7M | 8% |
| AUGTYRO | $836.0K | 1% |
